Valuation: Teva Pharmaceutical Industries Limited

Market Cap 42.11B 0 36.5B 34.17B 31.17B 58.66B 4,017B 59.65B 401B 157B 2,011B 158B 155B 6,707B P/E 2026 *
48.5x
P/E 2027 * 19.9x
Enterprise Value 53.99B 0 46.79B 43.8B 39.97B 75.21B 5,150B 76.47B 514B 201B 2,578B 203B 198B 8,599B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 2.93x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day+3.29%
1 week+6.28%
Current month+1.20%
1 month+11.79%
3 months+5.16%
6 months+4.76%
Current year+9.02%
1 week 10,180
Extreme 10180
11,080
1 month 9,396
Extreme 9396
11,080
Current year 8,860
Extreme 8860
11,350
1 year 5,580
Extreme 5580
11,350
3 years 3,250
Extreme 3250
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,750
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
+3.29%+6.28% - - 42.11B
-1.68%+9.06%+91.55%+130.32% 1,098B
-1.02%+1.98%+49.57%+49.54% 631B
+0.59%+2.53%+25.85%+64.27% 438B
-1.13%+3.13%+49.78%+39.13% 368B
-0.74%+1.01%+31.08%+38.64% 298B
-1.22%+0.89%+7.32%+7.38% 251B
-0.71%+6.17%+45.25%+57.75% 226B
+0.34%-0.13%-4.77%-50.50% 209B
+2.15%+0.86%+13.24%+70.52% 165B
Average +0.01%+1,657.21%+34.32%+45.23% 409.37B
Weighted average by Cap. -0.73%+1,331.50%+49.92%+66.33%

Financials

2026 *2027 *
Net sales 16.58B 0 14.37B 13.45B 12.27B 23.1B 1,582B 23.49B 158B 61.8B 792B 62.26B 60.9B 2,641B 17.3B 0 15B 14.04B 12.81B 24.1B 1,650B 24.51B 165B 64.49B 826B 64.97B 63.56B 2,756B
Net income 1.14B 0 988M 925M 844M 1.59B 109B 1.62B 10.85B 4.25B 54.44B 4.28B 4.19B 182B 2.34B 0 2.03B 1.9B 1.73B 3.26B 223B 3.31B 22.23B 8.71B 112B 8.77B 8.58B 372B
Net Debt 11.88B 0 10.29B 9.64B 8.79B 16.55B 1,133B 16.82B 113B 44.27B 567B 44.6B 43.62B 1,892B 8.61B 0 7.46B 6.99B 6.37B 11.99B 821B 12.2B 81.91B 32.09B 411B 32.33B 31.63B 1,371B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
11/08/26 ILA 11,000.00 +3.29% 1,255,242
10/08/26 ILA 10,650.00 +1.43% 920,617
07/08/26 ILA 10,500.00 +1.06% 277,587
06/08/26 ILA 10,390.00 -0.38% 3,144,670
05/08/26 ILA 10,430.00 +0.77% 974,961
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
36.14USD
Average target price
41.20USD
Spread / Average Target
+14.00%

Quarterly revenue - Rate of surprise